Prenatal genetic screening and diagnostic testing are used during pregnancy to check whether a baby may have certain genetic or chromosomal conditions. These tests are offered in the first and second trimesters and range from simple blood draws to more involved procedures.
Knowing what each test does and when it is offered can help you feel more informed as your pregnancy moves forward.
Screening vs. Diagnostic Testing: What’s the Difference?
One of the most important things to understand early in pregnancy is the difference between screening and diagnostic testing.
Screening tests estimate the chance that a baby has a certain condition. They do not provide a diagnosis. A result might come back as “low risk” or “higher risk,” which helps guide whether more testing is needed.
Diagnostic tests go a step further. They can confirm whether a specific genetic condition is actually present. These tests give more definitive answers, but they are also more invasive. That is why they are not done routinely for every pregnancy.
Many patients start with screening because it is less invasive and can offer early peace of mind. Others begin diagnostic testing, especially if they have a family history of genetic conditions or a prior affected pregnancy. There is no single correct choice. The best option is the one that fits your needs.
First Trimester Testing Options
Carrier screening looks at the parents rather than the baby. It checks whether you or your partner carry a gene for conditions like cystic fibrosis or spinal muscular atrophy.
This test works best when done before pregnancy, but it can also be done early in the first trimester. If both parents carry a gene for the same condition, there may be a higher chance the baby is affected.
Non-invasive prenatal testing (NIPT), also called cell-free DNA screening, is a blood test available starting around 10 weeks. It screens for common chromosomal conditions like trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. Some versions also look at sex chromosome differences.
NIPT is very accurate as a screening tool, but it does not provide a diagnosis on its own. A higher-risk result usually leads to a conversation about follow-up testing to confirm.
The nuchal translucency (NT) ultrasound is typically done between 11 and 14 weeks. It measures a small fluid-filled space at the back of the baby’s neck. A larger measurement can point to a higher chance of certain chromosomal conditions. Some practices pair this ultrasound with bloodwork to build an overall risk picture.
For families who want earlier diagnostic answers, chorionic villus sampling (CVS) is available around 10 to 13 weeks. This test collects a small sample of placental tissue to check for chromosomal conditions and certain genetic disorders. CVS can give results sooner than amniocentesis, but it does not screen for neural tube defects, so additional testing may be needed.
Second Trimester Testing Options
Alpha-fetoprotein (AFP) is a blood test that measures the levels of protein produced by the fetal liver, and screens for neural tube defects and certain abdominal wall defects. Depending on what was done earlier, you may be offered AFP alone or a quad screen, which measures several substances in the blood to estimate risk. Like other screening tests, these results show risk level rather than a diagnosis.
The anatomy ultrasound is one of the most anticipated appointments in pregnancy. It is usually done around 18 to 22 weeks and takes a detailed look at the baby’s brain, heart, spine, kidneys, placenta, and fluid levels. This is not a genetic test, but it can identify structural concerns that may call for closer attention.
A normal anatomy scan is reassuring, though not every condition shows up on imaging. Some concerns may not appear until later in pregnancy.
Amniocentesis is a diagnostic test usually done after 15 weeks. It collects a small sample of amniotic fluid that contains fetal cells. Those cells can confirm chromosomal conditions and allow for more detailed genetic testing. This test is offered when screening suggests higher risk, when an ultrasound raises a concern, or when there is a known genetic risk in the family.
What These Tests Can and Cannot Tell You
Prenatal testing is very helpful, but it is not a crystal ball. Screening tests show whether your baby’s risk of certain conditions is higher or lower. Diagnostic tests can confirm many chromosomal conditions, but they do not test for every possible genetic abnormality.
Ultrasound can catch many structural concerns, but not all of them. Some differences in the heart or brain may be subtle, and some conditions develop later. The best way to think about prenatal testing is that it reduces uncertainty without removing it completely.
Test results help your provider shape your prenatal care plan. Low-risk results often provide reassurance. Higher-risk results may lead to more counseling, extra imaging, or diagnostic testing. If a condition is confirmed, your care team may suggest closer monitoring, delivery planning, or working with pediatric specialists so the baby has access to the right care after birth.
Choosing a Testing Path That Fits Your Pregnancy
When deciding which tests to consider, it helps to think through a few things. Would you like early screening for peace of mind? Would you want a definitive answer if screening came back higher risk? Do you have a family history or other factors that raise your risk?
Some families want as much information as possible. Others prefer a more limited approach. Both are valid. If you are unsure where to start, preconception counseling or an early pregnancy visit can help you and your provider decide together.
Schedule an appointment with MyOBGYN to talk about your prenatal testing options and build a plan that works for your pregnancy. Book online or call (702) 463-2981.
